Organon & Co
718 hedge funds and large institutions have $2.94B invested in Organon & Co in 2023 Q4 according to their latest regulatory filings, with 133 funds opening new positions, 189 increasing their positions, 280 reducing their positions, and 136 closing their positions.
1.94% more ownership
Funds ownership: 77.8% → 79.74% (+1.9%)
2% less first-time investments, than exits
New positions opened: 133 | Existing positions closed: 136
2% less funds holding
Funds holding: 730 → 718 (-12)
11% less call options, than puts
Call options by funds: $39.8M | Put options by funds: $44.6M
15% less capital invested
Capital invested by funds: $3.45B → $2.94B (-$514M)
33% less repeat investments, than reductions
Existing positions increased: 189 | Existing positions reduced: 280
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| 1 |
BlackRock
New York
|
+$242M |
| 2 |
Morgan Stanley
New York
|
+$118M |
| 3 |
SPC
Slate Path Capital
New York
|
+$48.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$43.3M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$40.6M |
Top Sellers
| 1 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$223M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$116M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$87.3M |
| 4 |
State Street
Boston,
Massachusetts
|
-$58.2M |
| 5 |
Amundi
Paris,
France
|
-$32.1M |
OGN Hedge Fund Activity: Q4 2023 in Review
718 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q4 2023, worth a combined $2.94B — down 15% from $3.45B a quarter earlier.
Sellers outnumbered buyers: 136 funds closed out of OGN and 133 opened new positions — a net loss of 3 holders — while 280 trimmed existing stakes and 189 added.
The largest buyer was BlackRock, adding an estimated $242M. The largest seller was Mawer Investment Management, exiting entirely with an estimated $223M sold.
- 718 institutional investors held Organon & Co (OGN) as of Q4 2023, down from 730 in Q3 2023.
- Funds reported $2.94B of Organon & Co stock for Q4 2023, down 15% quarter-over-quarter.
- 133 funds opened new Organon & Co positions in Q4 2023 and 136 closed out, a net change of -3 holders.
- The largest Organon & Co buyer in Q4 2023 was BlackRock, an estimated $242M added.
- The largest Organon & Co seller in Q4 2023 was Mawer Investment Management, an estimated $223M sold.
Based on aggregated 13F filings for Q4 2023.